 |
 |
|
|
RESÚMENES JUNIO 2005 |
Basic Neuroscience & Pharmacology
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Nature Reviews Neuroscience 6, 423-434 (2005)
STRESS
AND THE BRAIN: FROM ADAPTATION TO DISEASE
Nature Reviews Neuroscience 6, 463-475 (2005)
Keith Matthews,
David Christmas, John Swan and Eleanor Sorrell
Neuroscience & Biobehavioral Reviews. Volume 29,
Issues 4-5, 2005, Pages 503-513
Alan Frazer and
David A. Morilak
Neuroscience & Biobehavioral Reviews. Volume 29,
Issues 4-5, 2005, Pages 515-523
Adrian J. Dunn,
Artur H. Swiergiel and Renaud de Beaurepaire
Neuroscience & Biobehavioral Reviews. Volume 29,
Issues 4-5, 2005, Pages 891-909
Distinct
effects of sleep deprivation on binding to norepinephrine and serotonin
transporters in rat brain
Débora C. Hipólide,
Karin M. Moreira, Karen B.L. Barlow, Alan A. Wilson, José N. Nobrega and Sergio
Tufik
Mice Lacking Dopamine D2 and D3 Receptors Exhibit Differential Activation of Prefrontal Cortical Neurons during Tasks Requiring Attention
Sara B. Glickstein, Deirdre A. DeSteno, Patrick R. Hof and Claudia
Schmauss
Cerebral Cortex 2005 15(7):1016-1024
E. Sastre, A.
Nicolay, B. Bruguerolle and H. Portugal
Life
Sciences. Volume 77, Issue 7, 1 July 2005, Pages 758-767
Oxidative stress mechanisms and potential therapeutics in Alzheimer
disease
P. I. Moreira,
S. L. Siedlak, G. Aliev, X. Zhu, A. D. Cash, M.
A. Smith and G. Perry
Journal of Neural Transmission 2005; Volume 112, Number
7: 921 - 932
A positron emission tomography (PET) study of cerebral dopamine D2
and serotonine 5-HT2A receptor occupancy in patients treated with
cyamemazine (Tercian)
Y. Hodé,
M. Reimold, A. Demazières, G. Reischl, F. Bayle,
P. Nuss, A. Hameg, M. Dib and J. P. Macher
Psychopharmacology 2005; Volume 180, Number
2: 377 - 384
Oxidative
stress during treatment with first- and second-generation antipsychotics.
Kropp S, Kern V, Lange K,
Degner D, Hajak G, Kornhuber J, Ruther E, Emrich HM, Schneider U, Bleich S
J Neuropsychiatry Clin Neurosci. 2005
Spring;17(2):227-31
High- and
low-affinity binding of S-citalopram to the human serotonin transporter mutated
at 20 putatively important amino acid positions
Per Plenge and Ove
Wiborg
Neuroscience
Letters. Volume 383, Issue 3, 5 August 2005, Pages 203-208
Nick J. Coupland,
Catherine J. Ogilvie, Kathleen M. Hegadoren, Peter Seres, Chris C. Hanstock and
Peter S. Allen
Biological Psychiatry. Volume 57, Issue 12, 15 June 2005, Pages
1526-1534
Ralf
Schneggenburger and Erwin Neher
Current Opinion in Neurobiology. Volume 15, Issue 3,
June 2005, Pages 266-274
René Marois and
Jason Ivanoff
Trends
in Cognitive Sciences. Volume 9, Issue 6, June 2005, Pages 296-305
Jeffrey L. Rausch,
Maria E. Johnson, Junqing Li, Julian Hutcheson,
Benjamin M. Carr, Katina M. Corley,
Amanda B. Gowans and Joseph Smith
Psychopharmacology 2005; Volume 180, Number
3: 391 - 398
Eugenio
Mocchegiani, Carlo Bertoni-Freddari, Fiorella Marcellini and Marco Malavolta
Progress in Neurobiology. Volume 75, Issue 6, April
2005, Pages 367-390
David Sulzer, Mark
S. Sonders, Nathan W. Poulsen and Aurelio Galli
Progress in Neurobiology. Volume 75, Issue 6, April
2005, Pages 406-433
Effects of Acute and Long-Term Administration of Escitalopram
and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological
Study in Rat Brain
Mostafa El Mansari, Connie
Sánchez, Guy Chouvet, Bernard Renaud and Nasser Haddjeri
Neuropsychopharmacology (2005) 30, 1269-1277
Comparison of Alterations in c-fos and Egr-1 (zif268)
Expression Throughout the Rat Brain Following Acute Administration of Different
Classes of Antidepressant Compounds
David A Slattery, John A Morrow,
Alan L Hudson, David R Hill, David J Nutt and Brian Henry
Neuropsychopharmacology (2005) 30, 1278-1287
Oscar P. Dall’igna, Adriano B.L. Tort, Diogo O. Souza, Diogo R. Lara
Journal of
Psychopharmacology, Vol. 19, No. 4, 342-346 (2005)
Long-lasting
cognitive improvement with nicotinic receptor agonists: mechanisms of
pharmacokinetic–pharmacodynamic discordance
Jerry J.
Buccafusco, Sharon R. Letchworth, Merouane Bencherif and Patrick M. Lippiello
Trends
in Pharmacological Sciences. Volume 26, Issue 7, July 2005, Pages 352-360
Combined
α2 and D2/3 receptor blockade enhances cortical
glutamatergic transmission and reverses cognitive impairment in the rat
Monica
M. Marcus, Kent E. Jardemark, Marie-Louise Wadenberg,
Xavier Langlois, Peter Hertel and Torgny H. Svensson
The International Journal of Neuropsychopharmacology
(2005), 8:3:315-327
Activation of
noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement
of glutamatergic mechanisms
Linda
K. Nilsson, Lilly Schwieler, Göran Engberg, Klas
R. Linderholm and Sophie Erhardt
The International Journal of Neuropsychopharmacology
(2005), 8:3:329-339
Novel
antipsychotics activate recombinant human and native rat serotonin 5-HT1A
receptors: affinity, efficacy and potential implications for treatment of
schizophrenia
Adrian Newman-Tancredi,
Marie-Bernadette Assié, Nathalie Leduc, Anne-Marie Ormière,
Nathalie Danty and Cristina Cosi
The International Journal of Neuropsychopharmacology
(2005), 8:3:341-356
The antidepressant
effect of running is associated with increased hippocampal cell proliferation
Astrid Bjørnebekk,
Aleksander A. Mathé and Stefan Brené
The International Journal of Neuropsychopharmacology
(2005), 8:3:357-368
Expression of Ndrg2
in the rat frontal cortex after antidepressant and electroconvulsive treatment
Kou Takahashi,
Misa Yamada, Hisayuki Ohata, Kazutaka Momose,
Teruhiko Higuchi, Kazuo Honda and Mitsuhiko Yamada
The International Journal of Neuropsychopharmacology
(2005), 8:3:381-389
Patients
with obsessive–compulsive disorder have increased 5-HT2A receptor
binding in the caudate nuclei
Karen
H. Adams, Elsebeth S. Hansen, Lars H. Pinborg, Steen
G. Hasselbalch, Claus Svarer, Søren Holm, Tom G. Bolwig and
Gitte M. Knudsen
The International Journal of Neuropsychopharmacology
(2005), 8:3:391-401
Neuropeptide Y and
corticotropin-releasing hormone in CSF mark response to antidepressive
treatment with citalopram
Georg Nikisch,
Hans Ågren, Chin B. Eap, Adelheid Czernik, Pierre Baumann
and Aleksander A. Mathé
The International Journal of Neuropsychopharmacology
(2005), 8:3:403-410
Combined analysis
of 635 patients confirms an age-related association of the serotonin 2A
receptor gene with tardive dyskinesia and specificity for the non-orofacial
subtype
Bernard Lerer,
Ronnen H. Segman, Ene-Choo Tan, Vincenzo S. Basile,
Roberto Cavallaro, Harald N. Aschauer, Rael Strous,
Siow-Ann Chong, Uriel Heresco-Levy, Massimiliano Verga,
Joachim Scharfetter, Herbert Y. Meltzer, James L. Kennedy and
Fabio Macciardi
The International Journal of Neuropsychopharmacology
(2005), 8:3:411-425
The
effect of exercise on hippocampal integrity: review of recent research.
Kiraly MA, Kiraly SJ
Int J Psychiatry Med. 2005;35(1):75-89
K Cooper-Casey, A Mésen-Fainardi, B Galke-Rollins,
M Llach, B Laprade, C Rodriguez, S Riondet, A Bertheau
and W Byerley
Molecular Psychiatry (2005) 10, 651−656
Changes in
prefrontal activity characterize clinical response in SSRI nonresponders: a
pilot study
Ian A. Cook, Andrew
F. Leuchter, Melinda L. Morgan, William Stubbeman, Barbara Siegman and Michelle
Abrams
Journal of Psychiatric Research. Volume 39, Issue 5,
September 2005, Pages 461-466
Impact
of Schizophrenia and Chronic Antipsychotic Treatment on [123I]CNS-1261
Binding to N-Methyl-D-Aspartate Receptors In Vivo
Rodrigo A. Bressan,
Kjell Erlandsson, James M. Stone, Rachel S. Mulligan, John H. Krystal, Peter J.
Ell and Lyn S. Pilowsky
Biological Psychiatry. Volume 58, Issue 1, 1 July 2005, Pages 41-46
Adenosine A2A,
but not A1, receptors mediate the arousal effect of caffeine
.